Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William G Wierda

Showing results (1-10 of 349) with videos related to

Pageof 35
Sort By:
Current Oncology Reports|August 5, 2003
Immunologic monitoring in chronic lymphocytic leukemiaWilliam G Wierda
Journal of the National Comprehensive Cancer Network : JNCCN|May 22, 2015
Updates to the management of chronic lymphocytic leukemiaWilliam G Wierda
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2016
Minimal Residual Disease Provides Treatment Focus for Next Chronic Lymphocytic Leukemia AdvancesWilliam G Wierda
NEJM Evidence|February 6, 2024
Ibrutinib Plus Venetoclax for First-Line Chronic Lymphocytic Leukemia TreatmentWilliam G Wierda
Clinical Advances in Hematology & Oncology : H&O|June 13, 2019
Does FCR have the potential to cure a subgroup of patients with chronic lymphocytic leukemia?William G Wierda
Clinical Advances in Hematology & Oncology : H&O|August 7, 2024
The approval of lisocabtagene maraleucel in chronic lymphocytic leukemiaWilliam G Wierda
Clinical Advances in Hematology & Oncology : H&O|February 5, 2025
Highlights in chronic lymphocytic leukemia from the 66th ASH Annual Meeting and Exposition: commentaryWilliam G Wierda
Hematology. American Society of Hematology. Education Program|November 25, 2006
Current and investigational therapies for patients with CLLWilliam G Wierda
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2012
Making advances in first-line chronic lymphocytic leukemia treatmentWilliam G Wierda
Neurology|October 31, 2018
Cerebral edema secondary to chimeric antigen receptor T-cell immunotherapyNandita Guha-Thakurta, William G Wierda
Pageof 35

Showing results (1-10 of 349) with videos related to

Sort By:
Pageof 35
Current Oncology Reports|August 5, 2003
Immunologic monitoring in chronic lymphocytic leukemiaWilliam G Wierda
Journal of the National Comprehensive Cancer Network : JNCCN|May 22, 2015
Updates to the management of chronic lymphocytic leukemiaWilliam G Wierda
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2016
Minimal Residual Disease Provides Treatment Focus for Next Chronic Lymphocytic Leukemia AdvancesWilliam G Wierda
NEJM Evidence|February 6, 2024
Ibrutinib Plus Venetoclax for First-Line Chronic Lymphocytic Leukemia TreatmentWilliam G Wierda
Clinical Advances in Hematology & Oncology : H&O|June 13, 2019
Does FCR have the potential to cure a subgroup of patients with chronic lymphocytic leukemia?William G Wierda
Clinical Advances in Hematology & Oncology : H&O|August 7, 2024
The approval of lisocabtagene maraleucel in chronic lymphocytic leukemiaWilliam G Wierda
Clinical Advances in Hematology & Oncology : H&O|February 5, 2025
Highlights in chronic lymphocytic leukemia from the 66th ASH Annual Meeting and Exposition: commentaryWilliam G Wierda
Hematology. American Society of Hematology. Education Program|November 25, 2006
Current and investigational therapies for patients with CLLWilliam G Wierda
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2012
Making advances in first-line chronic lymphocytic leukemia treatmentWilliam G Wierda
Neurology|October 31, 2018
Cerebral edema secondary to chimeric antigen receptor T-cell immunotherapyNandita Guha-Thakurta, William G Wierda
Pageof 35